In an effort to break even by…
In an effort to break even by 2028, mRNA specialist [...]
Sun Pharma has launched an…
Sun Pharma has launched an eye-opening awareness push about a [...]
Pfizer has released the full data…
Pfizer has released the full data from its phase 3 [...]
Genetic medicines outfit Ensoma is…
Genetic medicines outfit Ensoma is halving its workforce, with most [...]
Facing skepticism from analysts…
Facing skepticism from analysts about whether it has the resources [...]
Novartis may have signed off on…
Novartis may have signed off on the second-largest pharma acquisition [...]
New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases
Instead of requiring personalized gene edits for each patient, the [...]
Bayer’s Hyrnuo is catching up to…
Bayer’s Hyrnuo is catching up to Boehringer Ingelheim’s rival Hernexeos [...]
With a $140 million investment,…
With a $140 million investment, Moderna will build a new [...]
After laying off 80% of staffers…
After laying off 80% of staffers this spring, Tempest Therapeutics [...]